BioSpace News Archive

Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced the appointment of Mr. Eran Perry to its board of directors, effective July 1, 2019.

Premier Inc., through its ProvideGx™ program, is now supplying cysteine hydrochloride injection to providers, a critical drug for pediatric and adult patients that require total parenteral nutrition.

InMed Pharmaceuticals Inc., a biopharmaceutical company developing a proprietary biosynthesis technology for cannabinoid-based pharmaceuticals to treat severe diseases, announced the appointment of Catherine Sazdanoff, JD, to its Board of Directors.

Appili’s multi-drug resistant antibiotic program has the potential to address public health threats for both military and civilian populations worldwide

Reported sales of $3,246,038, an increase of 229% compared to the reported sales of $987,431 in the prior fiscal year.

Collaboration will expand potential to bring new medicines to patients with cancer around the world

Forbes Technology Council Is an Invitation-Only Community for World-Class CIOs, CTOs and Technology Executives

The American Association of Orthodontists has serious concerns about direct-to-consumer orthodontics when it sees over 935 “Customer Complaints” on the Better Business Bureau’s website for SmileDirectClub, LLC, as well as other reviews and stories where individuals are claiming issues with certain direct-to-consumer companies.

EnCann Solutions is announcing that Health Canada has granted an Industrial Hemp License.

Laser Clinics Australia, Australia’s largest retail aesthetics clinics chain and Kleresca®, an innovative Danish/Irish med-tech company focusing on fluorescent light energy in skin treatments have formed a strategic partnership whereby the Kleresca® FLE technology will be made available to the LCA customer base in Australia.